Disclosed herein are maytansinoid drug linker derivatives which can be linked to a antigen binding unit (Abu), and maytansinoid drugs linked with an antigen binding unit (Drug-Linker-Antigen binding Unit: D-L-Abu), for targeted delivery to disease tissues. D-L-Abu, D-L-Abu derivatives, and methods relating to the use of such drug conjugates to treat antigen positive cells in cancers and immunological disorders are provided.
本文披露了可以连接到抗原结合单元(Abu)的梅替西韦类药物连接剂衍
生物,以及与抗原结合单元连接的梅替西韦类药物(药物-连接剂-抗原结合单元:D-L-Abu),用于靶向传递至疾病组织。提供了与抗原阳性细胞在癌症和免疫性疾病中治疗此类药物结合物的相关方法。